Tower Research Capital LLC (TRC) FENC FENNEC PHARMACEUTICALS INC

Ownership history in Tower Research Capital LLC (TRC)  ·  30 quarters on record

AI Ownership Summary

Tower Research Capital LLC (TRC) reported FENNEC PHARMACEUTICALS INC (FENC) in 30 quarterly 13F filings from 2024 Q1 through 2026 Q2. The latest visible filing shows FENC at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this FENC ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Tower Research Capital LLC (TRC)'s position in FENNEC PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

FENC was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Tower Research Capital LLC (TRC) held FENC — position size vs. price
% of Fund (quarterly)    FENC price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 3,475 -864 -19.9% 0.00% $37K 2026-08-11 $nan
2026 Q1 ADDED 4,339 +2,955 +213.5% 0.00% $27K 2026-05-15 $9.75
2025 Q4 REDUCED 14.8% -20.1% 1,384 -240 -14.8% 0.00% $11K 2026-02-17 $8.68
2025 Q3 REDUCED 74.9% -17.8% 1,624 -4,836 -74.9% 0.00% $15K 2025-11-14 $7.86
2025 Q2 ADDED 6,460 +4,765 +281.1% 0.00% $54K 2025-08-15 $8.36
2025 Q1 REDUCED 22.8% +36.3% 1,695 -501 -22.8% 0.00% $10K 2025-05-15 $6.55
2024 Q4 REDUCED 10.3% -3.6% 2,196 -253 -10.3% 0.00% $14K 2025-02-13 $6.74
2024 Q3 REDUCED 46.1% +23.2% 2,449 -2,098 -46.1% 0.00% $12K 2024-11-14 $4.40
2024 Q2 ADDED 4,547 +4,157 +1065.9% 0.00% $28K 2024-08-13 $5.85
2024 Q1 REDUCED 87.2% -43.6% 390 -2,658 -87.2% 0.00% $4K 2024-05-15 $6.98
20 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Tower Research Capital LLC (TRC) and FENC

These are the practical questions this page is built to answer before you even open the full history table.

How long has Tower Research Capital LLC (TRC) reported owning FENC?

Tower Research Capital LLC (TRC) reported FENC across 10 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported FENC position in Tower Research Capital LLC (TRC)'s portfolio?

The largest reported portfolio weight for FENC was 0.00% in 2025 Q2.

What is the latest reported FENC position on this page?

The most recent filing on this page is 2026 Q2, when Tower Research Capital LLC (TRC) reported 3,475 shares, equal to 0.00% of portfolio, with an estimated market value of $37K.

What does the chart on this FENC ownership page compare?

The chart compares Tower Research Capital LLC (TRC)'s quarterly FENC portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Tower Research Capital LLC (TRC) time their FENC position?

Based on 13F filing dates vs. subsequent FENC price moves, Tower Research Capital LLC (TRC) correctly timed 13 out of 29 reported position changes (45%). The annualised alpha on FENC relative to SPY over the holding period was -25.0%.

← Back to Tower Research Capital LLC (TRC) Holdings